Global Antibiotic API Market Growth 2022-2028
As the global economy mends, the 2021 growth of Antibiotic API will have significant change from previous year. According to our latest study, the global Antibiotic API market size is USD million in 2022 from USD 5319.6 million in 2021, with a change of % between 2021 and 2022. The global Antibiotic API market size will reach USD 4837.3 million in 2028, growing at a CAGR of -1.3% over the analysis period.
The United States Antibiotic API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antibiotic API market, reaching US$ million by the year 2028. As for the Europe Antibiotic API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antibiotic API players cover UNITED LABORATORIES, North China Pharmaceutical, RUIYING PIONEER PHARMACEUTICAL, and Centrient Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibiotic API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Penicillins
Cephalosporins
Aminoglycosides
Tetracyclines
Quinolones
Macrolides
Lincomycins
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oral Medicine
Injection Medicine
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibiotic API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Antibiotic API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Antibiotic API by Country/Region, 2017, 2022 & 2028
2.2 Antibiotic API Segment by Type
2.2.1 Penicillins
2.2.2 Cephalosporins
2.2.3 Aminoglycosides
2.2.4 Tetracyclines
2.2.5 Quinolones
2.2.6 Macrolides
2.2.7 Lincomycins
2.2.8 Others
2.3 Antibiotic API Sales by Type
2.3.1 Global Antibiotic API Sales Market Share by Type (2017-2022)
2.3.2 Global Antibiotic API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Antibiotic API Sale Price by Type (2017-2022)
2.4 Antibiotic API Segment by Application
2.4.1 Oral Medicine
2.4.2 Injection Medicine
2.5 Antibiotic API Sales by Application
2.5.1 Global Antibiotic API Sale Market Share by Application (2017-2022)
2.5.2 Global Antibiotic API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Antibiotic API Sale Price by Application (2017-2022)
3 Global Antibiotic API by Company
3.1 Global Antibiotic API Breakdown Data by Company
3.1.1 Global Antibiotic API Annual Sales by Company (2020-2022)
3.1.2 Global Antibiotic API Sales Market Share by Company (2020-2022)
3.2 Global Antibiotic API Annual Revenue by Company (2020-2022)
3.2.1 Global Antibiotic API Revenue by Company (2020-2022)
3.2.2 Global Antibiotic API Revenue Market Share by Company (2020-2022)
3.3 Global Antibiotic API Sale Price by Company
3.4 Key Manufacturers Antibiotic API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibiotic API Product Location Distribution
3.4.2 Players Antibiotic API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antibiotic API by Geographic Region
4.1 World Historic Antibiotic API Market Size by Geographic Region (2017-2022)
4.1.1 Global Antibiotic API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Antibiotic API Annual Revenue by Geographic Region
4.2 World Historic Antibiotic API Market Size by Country/Region (2017-2022)
4.2.1 Global Antibiotic API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Antibiotic API Annual Revenue by Country/Region
4.3 Americas Antibiotic API Sales Growth
4.4 APAC Antibiotic API Sales Growth
4.5 Europe Antibiotic API Sales Growth
4.6 Middle East & Africa Antibiotic API Sales Growth
5 Americas
5.1 Americas Antibiotic API Sales by Country
5.1.1 Americas Antibiotic API Sales by Country (2017-2022)
5.1.2 Americas Antibiotic API Revenue by Country (2017-2022)
5.2 Americas Antibiotic API Sales by Type
5.3 Americas Antibiotic API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibiotic API Sales by Region
6.1.1 APAC Antibiotic API Sales by Region (2017-2022)
6.1.2 APAC Antibiotic API Revenue by Region (2017-2022)
6.2 APAC Antibiotic API Sales by Type
6.3 APAC Antibiotic API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antibiotic API by Country
7.1.1 Europe Antibiotic API Sales by Country (2017-2022)
7.1.2 Europe Antibiotic API Revenue by Country (2017-2022)
7.2 Europe Antibiotic API Sales by Type
7.3 Europe Antibiotic API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibiotic API by Country
8.1.1 Middle East & Africa Antibiotic API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Antibiotic API Revenue by Country (2017-2022)
8.2 Middle East & Africa Antibiotic API Sales by Type
8.3 Middle East & Africa Antibiotic API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibiotic API
10.3 Manufacturing Process Analysis of Antibiotic API
10.4 Industry Chain Structure of Antibiotic API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibiotic API Distributors
11.3 Antibiotic API Customer
12 World Forecast Review for Antibiotic API by Geographic Region
12.1 Global Antibiotic API Market Size Forecast by Region
12.1.1 Global Antibiotic API Forecast by Region (2023-2028)
12.1.2 Global Antibiotic API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antibiotic API Forecast by Type
12.7 Global Antibiotic API Forecast by Application
13 Key Players Analysis
13.1 UNITED LABORATORIES
13.1.1 UNITED LABORATORIES Company Information
13.1.2 UNITED LABORATORIES Antibiotic API Product Offered
13.1.3 UNITED LABORATORIES Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 UNITED LABORATORIES Main Business Overview
13.1.5 UNITED LABORATORIES Latest Developments
13.2 North China Pharmaceutical
13.2.1 North China Pharmaceutical Company Information
13.2.2 North China Pharmaceutical Antibiotic API Product Offered
13.2.3 North China Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 North China Pharmaceutical Main Business Overview
13.2.5 North China Pharmaceutical Latest Developments
13.3 RUIYING PIONEER PHARMACEUTICAL
13.3.1 RUIYING PIONEER PHARMACEUTICAL Company Information
13.3.2 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Offered
13.3.3 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 RUIYING PIONEER PHARMACEUTICAL Main Business Overview
13.3.5 RUIYING PIONEER PHARMACEUTICAL Latest Developments
13.4 Centrient Pharmaceuticals
13.4.1 Centrient Pharmaceuticals Company Information
13.4.2 Centrient Pharmaceuticals Antibiotic API Product Offered
13.4.3 Centrient Pharmaceuticals Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Centrient Pharmaceuticals Main Business Overview
13.4.5 Centrient Pharmaceuticals Latest Developments
13.5 Aurobindo Pharma
13.5.1 Aurobindo Pharma Company Information
13.5.2 Aurobindo Pharma Antibiotic API Product Offered
13.5.3 Aurobindo Pharma Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Aurobindo Pharma Main Business Overview
13.5.5 Aurobindo Pharma Latest Developments
13.6 Shyndec Pharmaceutical
13.6.1 Shyndec Pharmaceutical Company Information
13.6.2 Shyndec Pharmaceutical Antibiotic API Product Offered
13.6.3 Shyndec Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Shyndec Pharmaceutical Main Business Overview
13.6.5 Shyndec Pharmaceutical Latest Developments
13.7 Nectar Lifesciences
13.7.1 Nectar Lifesciences Company Information
13.7.2 Nectar Lifesciences Antibiotic API Product Offered
13.7.3 Nectar Lifesciences Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Nectar Lifesciences Main Business Overview
13.7.5 Nectar Lifesciences Latest Developments
13.8 Harbin Pharmaceutical Group
13.8.1 Harbin Pharmaceutical Group Company Information
13.8.2 Harbin Pharmaceutical Group Antibiotic API Product Offered
13.8.3 Harbin Pharmaceutical Group Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Harbin Pharmaceutical Group Main Business Overview
13.8.5 Harbin Pharmaceutical Group Latest Developments
13.9 ACS Dobfar
13.9.1 ACS Dobfar Company Information
13.9.2 ACS Dobfar Antibiotic API Product Offered
13.9.3 ACS Dobfar Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 ACS Dobfar Main Business Overview
13.9.5 ACS Dobfar Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Antibiotic API Product Offered
13.10.3 Novartis Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 CSPC
13.11.1 CSPC Company Information
13.11.2 CSPC Antibiotic API Product Offered
13.11.3 CSPC Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 CSPC Main Business Overview
13.11.5 CSPC Latest Developments
13.12 QILU ANTIBIOTICS PHARMACEUTICAL
13.12.1 QILU ANTIBIOTICS PHARMACEUTICAL Company Information
13.12.2 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Offered
13.12.3 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 QILU ANTIBIOTICS PHARMACEUTICAL Main Business Overview
13.12.5 QILU ANTIBIOTICS PHARMACEUTICAL Latest Developments
13.13 REYOUNG
13.13.1 REYOUNG Company Information
13.13.2 REYOUNG Antibiotic API Product Offered
13.13.3 REYOUNG Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 REYOUNG Main Business Overview
13.13.5 REYOUNG Latest Developments
13.14 Orchid Pharma
13.14.1 Orchid Pharma Company Information
13.14.2 Orchid Pharma Antibiotic API Product Offered
13.14.3 Orchid Pharma Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Orchid Pharma Main Business Overview
13.14.5 Orchid Pharma Latest Developments
13.15 FUAN PHARMACEUTICAL
13.15.1 FUAN PHARMACEUTICAL Company Information
13.15.2 FUAN PHARMACEUTICAL Antibiotic API Product Offered
13.15.3 FUAN PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 FUAN PHARMACEUTICAL Main Business Overview
13.15.5 FUAN PHARMACEUTICAL Latest Developments
13.16 Dongying Pharmaceutical
13.16.1 Dongying Pharmaceutical Company Information
13.16.2 Dongying Pharmaceutical Antibiotic API Product Offered
13.16.3 Dongying Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Dongying Pharmaceutical Main Business Overview
13.16.5 Dongying Pharmaceutical Latest Developments
13.17 FUKANG PHARMACEUTICAL
13.17.1 FUKANG PHARMACEUTICAL Company Information
13.17.2 FUKANG PHARMACEUTICAL Antibiotic API Product Offered
13.17.3 FUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 FUKANG PHARMACEUTICAL Main Business Overview
13.17.5 FUKANG PHARMACEUTICAL Latest Developments
13.18 Medya Pharmaceutical
13.18.1 Medya Pharmaceutical Company Information
13.18.2 Medya Pharmaceutical Antibiotic API Product Offered
13.18.3 Medya Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Medya Pharmaceutical Main Business Overview
13.18.5 Medya Pharmaceutical Latest Developments
13.19 LUKANG PHARMACEUTICAL
13.19.1 LUKANG PHARMACEUTICAL Company Information
13.19.2 LUKANG PHARMACEUTICAL Antibiotic API Product Offered
13.19.3 LUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 LUKANG PHARMACEUTICAL Main Business Overview
13.19.5 LUKANG PHARMACEUTICAL Latest Developments
13.20 Dawnrays Pharmaceutical
13.20.1 Dawnrays Pharmaceutical Company Information
13.20.2 Dawnrays Pharmaceutical Antibiotic API Product Offered
13.20.3 Dawnrays Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Dawnrays Pharmaceutical Main Business Overview
13.20.5 Dawnrays Pharmaceutical Latest Developments
13.21 SALUBRIS
13.21.1 SALUBRIS Company Information
13.21.2 SALUBRIS Antibiotic API Product Offered
13.21.3 SALUBRIS Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 SALUBRIS Main Business Overview
13.21.5 SALUBRIS Latest Developments
13.22 KELUN
13.22.1 KELUN Company Information
13.22.2 KELUN Antibiotic API Product Offered
13.22.3 KELUN Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 KELUN Main Business Overview
13.22.5 KELUN Latest Developments
13.23 HUAFANG PHARMACEUTICAL
13.23.1 HUAFANG PHARMACEUTICAL Company Information
13.23.2 HUAFANG PHARMACEUTICAL Antibiotic API Product Offered
13.23.3 HUAFANG PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 HUAFANG PHARMACEUTICAL Main Business Overview
13.23.5 HUAFANG PHARMACEUTICAL Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Antibiotic API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antibiotic API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Penicillins
Table 4. Major Players of Cephalosporins
Table 5. Major Players of Aminoglycosides
Table 6. Major Players of Tetracyclines
Table 7. Major Players of Quinolones
Table 8. Major Players of Macrolides
Table 9. Major Players of Lincomycins
Table 10. Major Players of Others
Table 11. Global Antibiotic API Sales by Type (2017-2022) & (Tons)
Table 12. Global Antibiotic API Sales Market Share by Type (2017-2022)
Table 13. Global Antibiotic API Revenue by Type (2017-2022) & ($ million)
Table 14. Global Antibiotic API Revenue Market Share by Type (2017-2022)
Table 15. Global Antibiotic API Sale Price by Type (2017-2022) & (USD/Kg)
Table 16. Global Antibiotic API Sales by Application (2017-2022) & (Tons)
Table 17. Global Antibiotic API Sales Market Share by Application (2017-2022)
Table 18. Global Antibiotic API Revenue by Application (2017-2022)
Table 19. Global Antibiotic API Revenue Market Share by Application (2017-2022)
Table 20. Global Antibiotic API Sale Price by Application (2017-2022) & (USD/Kg)
Table 21. Global Antibiotic API Sales by Company (2020-2022) & (Tons)
Table 22. Global Antibiotic API Sales Market Share by Company (2020-2022)
Table 23. Global Antibiotic API Revenue by Company (2020-2022) ($ Millions)
Table 24. Global Antibiotic API Revenue Market Share by Company (2020-2022)
Table 25. Global Antibiotic API Sale Price by Company (2020-2022) & (USD/Kg)
Table 26. Key Manufacturers Antibiotic API Producing Area Distribution and Sales Area
Table 27. Players Antibiotic API Products Offered
Table 28. Antibiotic API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Antibiotic API Sales by Geographic Region (2017-2022) & (Tons)
Table 32. Global Antibiotic API Sales Market Share Geographic Region (2017-2022)
Table 33. Global Antibiotic API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 34. Global Antibiotic API Revenue Market Share by Geographic Region (2017-2022)
Table 35. Global Antibiotic API Sales by Country/Region (2017-2022) & (Tons)
Table 36. Global Antibiotic API Sales Market Share by Country/Region (2017-2022)
Table 37. Global Antibiotic API Revenue by Country/Region (2017-2022) & ($ millions)
Table 38. Global Antibiotic API Revenue Market Share by Country/Region (2017-2022)
Table 39. Americas Antibiotic API Sales by Country (2017-2022) & (Tons)
Table 40. Americas Antibiotic API Sales Market Share by Country (2017-2022)
Table 41. Americas Antibiotic API Revenue by Country (2017-2022) & ($ Millions)
Table 42. Americas Antibiotic API Revenue Market Share by Country (2017-2022)
Table 43. Americas Antibiotic API Sales by Type (2017-2022) & (Tons)
Table 44. Americas Antibiotic API Sales Market Share by Type (2017-2022)
Table 45. Americas Antibiotic API Sales by Application (2017-2022) & (Tons)
Table 46. Americas Antibiotic API Sales Market Share by Application (2017-2022)
Table 47. APAC Antibiotic API Sales by Region (2017-2022) & (Tons)
Table 48. APAC Antibiotic API Sales Market Share by Region (2017-2022)
Table 49. APAC Antibiotic API Revenue by Region (2017-2022) & ($ Millions)
Table 50. APAC Antibiotic API Revenue Market Share by Region (2017-2022)
Table 51. APAC Antibiotic API Sales by Type (2017-2022) & (Tons)
Table 52. APAC Antibiotic API Sales Market Share by Type (2017-2022)
Table 53. APAC Antibiotic API Sales by Application (2017-2022) & (Tons)
Table 54. APAC Antibiotic API Sales Market Share by Application (2017-2022)
Table 55. Europe Antibiotic API Sales by Country (2017-2022) & (Tons)
Table 56. Europe Antibiotic API Sales Market Share by Country (2017-2022)
Table 57. Europe Antibiotic API Revenue by Country (2017-2022) & ($ Millions)
Table 58. Europe Antibiotic API Revenue Market Share by Country (2017-2022)
Table 59. Europe Antibiotic API Sales by Type (2017-2022) & (Tons)
Table 60. Europe Antibiotic API Sales Market Share by Type (2017-2022)
Table 61. Europe Antibiotic API Sales by Application (2017-2022) & (Tons)
Table 62. Europe Antibiotic API Sales Market Share by Application (2017-2022)
Table 63. Middle East & Africa Antibiotic API Sales by Country (2017-2022) & (Tons)
Table 64. Middle East & Africa Antibiotic API Sales Market Share by Country (2017-2022)
Table 65. Middle East & Africa Antibiotic API Revenue by Country (2017-2022) & ($ Millions)
Table 66. Middle East & Africa Antibiotic API Revenue Market Share by Country (2017-2022)
Table 67. Middle East & Africa Antibiotic API Sales by Type (2017-2022) & (Tons)
Table 68. Middle East & Africa Antibiotic API Sales Market Share by Type (2017-2022)
Table 69. Middle East & Africa Antibiotic API Sales by Application (2017-2022) & (Tons)
Table 70. Middle East & Africa Antibiotic API Sales Market Share by Application (2017-2022)
Table 71. Key Market Drivers & Growth Opportunities of Antibiotic API
Table 72. Key Market Challenges & Risks of Antibiotic API
Table 73. Key Industry Trends of Antibiotic API
Table 74. Antibiotic API Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Antibiotic API Distributors List
Table 77. Antibiotic API Customer List
Table 78. Global Antibiotic API Sales Forecast by Region (2023-2028) & (Tons)
Table 79. Global Antibiotic API Sales Market Forecast by Region
Table 80. Global Antibiotic API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Global Antibiotic API Revenue Market Share Forecast by Region (2023-2028)
Table 82. Americas Antibiotic API Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Americas Antibiotic API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. APAC Antibiotic API Sales Forecast by Region (2023-2028) & (Tons)
Table 85. APAC Antibiotic API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 86. Europe Antibiotic API Sales Forecast by Country (2023-2028) & (Tons)
Table 87. Europe Antibiotic API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Middle East & Africa Antibiotic API Sales Forecast by Country (2023-2028) & (Tons)
Table 89. Middle East & Africa Antibiotic API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 90. Global Antibiotic API Sales Forecast by Type (2023-2028) & (Tons)
Table 91. Global Antibiotic API Sales Market Share Forecast by Type (2023-2028)
Table 92. Global Antibiotic API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 93. Global Antibiotic API Revenue Market Share Forecast by Type (2023-2028)
Table 94. Global Antibiotic API Sales Forecast by Application (2023-2028) & (Tons)
Table 95. Global Antibiotic API Sales Market Share Forecast by Application (2023-2028)
Table 96. Global Antibiotic API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 97. Global Antibiotic API Revenue Market Share Forecast by Application (2023-2028)
Table 98. UNITED LABORATORIES Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 99. UNITED LABORATORIES Antibiotic API Product Offered
Table 100. UNITED LABORATORIES Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 101. UNITED LABORATORIES Main Business
Table 102. UNITED LABORATORIES Latest Developments
Table 103. North China Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 104. North China Pharmaceutical Antibiotic API Product Offered
Table 105. North China Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 106. North China Pharmaceutical Main Business
Table 107. North China Pharmaceutical Latest Developments
Table 108. RUIYING PIONEER PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 109. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Offered
Table 110. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 111. RUIYING PIONEER PHARMACEUTICAL Main Business
Table 112. RUIYING PIONEER PHARMACEUTICAL Latest Developments
Table 113. Centrient Pharmaceuticals Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 114. Centrient Pharmaceuticals Antibiotic API Product Offered
Table 115. Centrient Pharmaceuticals Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 116. Centrient Pharmaceuticals Main Business
Table 117. Centrient Pharmaceuticals Latest Developments
Table 118. Aurobindo Pharma Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 119. Aurobindo Pharma Antibiotic API Product Offered
Table 120. Aurobindo Pharma Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 121. Aurobindo Pharma Main Business
Table 122. Aurobindo Pharma Latest Developments
Table 123. Shyndec Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 124. Shyndec Pharmaceutical Antibiotic API Product Offered
Table 125. Shyndec Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 126. Shyndec Pharmaceutical Main Business
Table 127. Shyndec Pharmaceutical Latest Developments
Table 128. Nectar Lifesciences Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 129. Nectar Lifesciences Antibiotic API Product Offered
Table 130. Nectar Lifesciences Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 131. Nectar Lifesciences Main Business
Table 132. Nectar Lifesciences Latest Developments
Table 133. Harbin Pharmaceutical Group Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 134. Harbin Pharmaceutical Group Antibiotic API Product Offered
Table 135. Harbin Pharmaceutical Group Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 136. Harbin Pharmaceutical Group Main Business
Table 137. Harbin Pharmaceutical Group Latest Developments
Table 138. ACS Dobfar Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 139. ACS Dobfar Antibiotic API Product Offered
Table 140. ACS Dobfar Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 141. ACS Dobfar Main Business
Table 142. ACS Dobfar Latest Developments
Table 143. Novartis Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 144. Novartis Antibiotic API Product Offered
Table 145. Novartis Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 146. Novartis Main Business
Table 147. Novartis Latest Developments
Table 148. CSPC Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 149. CSPC Antibiotic API Product Offered
Table 150. CSPC Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 151. CSPC Main Business
Table 152. CSPC Latest Developments
Table 153. QILU ANTIBIOTICS PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 154. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Offered
Table 155. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 156. QILU ANTIBIOTICS PHARMACEUTICAL Main Business
Table 157. QILU ANTIBIOTICS PHARMACEUTICAL Latest Developments
Table 158. REYOUNG Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 159. REYOUNG Antibiotic API Product Offered
Table 160. REYOUNG Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 161. REYOUNG Main Business
Table 162. REYOUNG Latest Developments
Table 163. Orchid Pharma Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 164. Orchid Pharma Antibiotic API Product Offered
Table 165. Orchid Pharma Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 166. Orchid Pharma Main Business
Table 167. Orchid Pharma Latest Developments
Table 168. FUAN PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 169. FUAN PHARMACEUTICAL Antibiotic API Product Offered
Table 170. FUAN PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 171. FUAN PHARMACEUTICAL Main Business
Table 172. FUAN PHARMACEUTICAL Latest Developments
Table 173. Dongying Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 174. Dongying Pharmaceutical Antibiotic API Product Offered
Table 175. Dongying Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 176. Dongying Pharmaceutical Main Business
Table 177. Dongying Pharmaceutical Latest Developments
Table 178. FUKANG PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 179. FUKANG PHARMACEUTICAL Antibiotic API Product Offered
Table 180. FUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 181. FUKANG PHARMACEUTICAL Main Business
Table 182. FUKANG PHARMACEUTICAL Latest Developments
Table 183. Medya Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 184. Medya Pharmaceutical Antibiotic API Product Offered
Table 185. Medya Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 186. Medya Pharmaceutical Main Business
Table 187. Medya Pharmaceutical Latest Developments
Table 188. LUKANG PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 189. LUKANG PHARMACEUTICAL Antibiotic API Product Offered
Table 190. LUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 191. LUKANG PHARMACEUTICAL Main Business
Table 192. LUKANG PHARMACEUTICAL Latest Developments
Table 193. Dawnrays Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 194. Dawnrays Pharmaceutical Antibiotic API Product Offered
Table 195. Dawnrays Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 196. Dawnrays Pharmaceutical Main Business
Table 197. Dawnrays Pharmaceutical Latest Developments
Table 198. SALUBRIS Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 199. SALUBRIS Antibiotic API Product Offered
Table 200. SALUBRIS Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 201. SALUBRIS Main Business
Table 202. SALUBRIS Latest Developments
Table 203. KELUN Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 204. KELUN Antibiotic API Product Offered
Table 205. KELUN Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 206. KELUN Main Business
Table 207. KELUN Latest Developments
Table 208. HUAFANG PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 209. HUAFANG PHARMACEUTICAL Antibiotic API Product Offered
Table 210. HUAFANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 211. HUAFANG PHARMACEUTICAL Main Business
Table 212. HUAFANG PHARMACEUTICAL Latest Developments
List of Figures
Figure 1. Picture of Antibiotic API
Figure 2. Antibiotic API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibiotic API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Antibiotic API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antibiotic API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Penicillins
Figure 10. Product Picture of Cephalosporins
Figure 11. Product Picture of Aminoglycosides
Figure 12. Product Picture of Tetracyclines
Figure 13. Product Picture of Quinolones
Figure 14. Product Picture of Macrolides
Figure 15. Product Picture of Lincomycins
Figure 16. Product Picture of Others
Figure 17. Global Antibiotic API Sales Market Share by Type in 2021
Figure 18. Global Antibiotic API Revenue Market Share by Type (2017-2022)
Figure 19. Antibiotic API Consumed in Oral Medicine
Figure 20. Global Antibiotic API Market: Oral Medicine (2017-2022) & (Tons)
Figure 21. Antibiotic API Consumed in Injection Medicine
Figure 22. Global Antibiotic API Market: Injection Medicine (2017-2022) & (Tons)
Figure 23. Global Antibiotic API Sales Market Share by Application (2017-2022)
Figure 24. Global Antibiotic API Revenue Market Share by Application in 2021
Figure 25. Antibiotic API Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Antibiotic API Revenue Market Share by Company in 2021
Figure 27. Global Antibiotic API Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Antibiotic API Revenue Market Share by Geographic Region in 2021
Figure 29. Global Antibiotic API Sales Market Share by Region (2017-2022)
Figure 30. Global Antibiotic API Revenue Market Share by Country/Region in 2021
Figure 31. Americas Antibiotic API Sales 2017-2022 (Tons)
Figure 32. Americas Antibiotic API Revenue 2017-2022 ($ Millions)
Figure 33. APAC Antibiotic API Sales 2017-2022 (Tons)
Figure 34. APAC Antibiotic API Revenue 2017-2022 ($ Millions)
Figure 35. Europe Antibiotic API Sales 2017-2022 (Tons)
Figure 36. Europe Antibiotic API Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Antibiotic API Sales 2017-2022 (Tons)
Figure 38. Middle East & Africa Antibiotic API Revenue 2017-2022 ($ Millions)
Figure 39. Americas Antibiotic API Sales Market Share by Country in 2021
Figure 40. Americas Antibiotic API Revenue Market Share by Country in 2021
Figure 41. United States Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Antibiotic API Sales Market Share by Region in 2021
Figure 46. APAC Antibiotic API Revenue Market Share by Regions in 2021
Figure 47. China Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Antibiotic API Sales Market Share by Country in 2021
Figure 54. Europe Antibiotic API Revenue Market Share by Country in 2021
Figure 55. Germany Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Antibiotic API Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Antibiotic API Revenue Market Share by Country in 2021
Figure 62. Egypt Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Antibiotic API Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Antibiotic API in 2021
Figure 68. Manufacturing Process Analysis of Antibiotic API
Figure 69. Industry Chain Structure of Antibiotic API
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
